DUBLIN–(BUSINESS WIRE)–The “Europe Virtual Clinical Trials Market By Study Type, By Indication, By Country, Industry Analysis and Forecast, 2020 – 2026” report has been added to ResearchAndMarkets.com’s offering.
The Europe Virtual Clinical Trials Market is expected to witness market growth of 7.3% CAGR during the forecast period (2020-2026).
Another name for virtual trials is decentralized trials. Virtual trials have a major role to play in the current COVID-19 pandemic and are likely to be a rule in the ways trials and real-world research are run. A virtual technique permits people to participate in the trial from the comfort of their homes which ensures that studies can be continued even when site visits are not feasible. Furthermore, it is a unique method of gathering secure and effective data from participants of clinical researches.
Recently, a rise in the complexity and volume of clinical trials has been observed, which have a significant role to play in the R&D of new drugs and other items. Besides, the cost of clinical trials has been increasing, contributing to the overall cost of creating a drug. Therefore, large pharmaceuticals and small biotechnology companies are searching for innovative methods to enhance trial results and reduce the costs of the trial.
Monitoring of remote patients and virtual visits to physical site visits provide members a choice and comfort of not prone to unnecessary dangers. The virtual examination empowers sponsors to include a bigger population in the research, hence enhancing recruitment, engagement, and retention. Besides, it allows continuous and real-time collection of data with the help of digital health technologies. Finally, virtual connectivity, management, and monitoring can majorly reduce the effort, participants’ burden and time commitments, CRCs, and investigators.
Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Companies Profiled
- IQVIA Holdings, Inc.
- ICON PLC
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Oracle Corporation
- Parexel International Corporation (Pamplona Capital Management)
- PRA Health Sciences, Inc. (KKR & Co., Inc.)
- Medpace Holdings, Inc.
- Medable, Inc.
- Clinical Ink, Inc. (G.I. Partners)
Unique Offerings
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. Europe Virtual Clinical Trials Market by Study Type
4.1 Europe Interventional Market by Country
4.2 Europe Observational Market by Country
4.3 Europe Expanded Access Market by Country
Chapter 5. Europe Virtual Clinical Trials Market by Indication
5.1 Europe Oncology Market by Country
5.2 Europe Cardiovascular Market by Country
5.3 Europe Immunology Market by Country
5.4 Europe Gastrointestinal Market by Country
5.5 Europe Respiratory Market by Country
5.6 Europe Endocrinology Market by Country
5.7 Europe Ophthalmology Market by Country
5.8 Europe Other Indications Market by Country
Chapter 6. Europe Virtual Clinical Trials Market by Country
6.1 Germany Virtual Clinical Trials Market
6.1.1 Germany Virtual Clinical Trials Market by Study Type
6.1.2 Germany Virtual Clinical Trials Market by Indication
6.2 UK Virtual Clinical Trials Market
6.2.1 UK Virtual Clinical Trials Market by Study Type
6.2.2 UK Virtual Clinical Trials Market by Indication
6.3 France Virtual Clinical Trials Market
6.3.1 France Virtual Clinical Trials Market by Study Type
6.3.2 France Virtual Clinical Trials Market by Indication
6.4 Russia Virtual Clinical Trials Market
6.4.1 Russia Virtual Clinical Trials Market by Study Type
6.4.2 Russia Virtual Clinical Trials Market by Indication
6.5 Spain Virtual Clinical Trials Market
6.5.1 Spain Virtual Clinical Trials Market by Study Type
6.5.2 Spain Virtual Clinical Trials Market by Indication
6.6 Italy Virtual Clinical Trials Market
6.6.1 Italy Virtual Clinical Trials Market by Study Type
6.6.2 Italy Virtual Clinical Trials Market by Indication
6.7 Rest of Europe Virtual Clinical Trials Market
6.7.1 Rest of Europe Virtual Clinical Trials Market by Study Type
6.7.2 Rest of Europe Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/2e8ucl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900